US Broker Ratings

ATAI Life Sciences (ATAI): Biotechnology Stock with a 300% Upside Potential

Investors looking for high-potential opportunities in the biotech sector may find ATAI Life Sciences N.V. (NASDAQ: ATAI) an intriguing option. This Berlin-based clinical-stage biopharmaceutical company is..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a Notable Revenue Growth

Investors interested in the healthcare sector, specifically medical care facilities, should take a closer look at Sonida Senior Living, Inc. (NYSE: SNDA). With an impressive revenue..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Unveiling a 196% Upside Potential in Biotech

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing the attention of investors with its promise of significant potential upside. As a clinical-stage biopharmaceutical company based in Boston,..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 96% Potential Upside with Breakthrough Precision Medicines

Maze Therapeutics, Inc. (NASDAQ: MAZE), a promising player in the biotechnology sector, is capturing investor attention with its cutting-edge approach in developing precision medicines. Based in..

Verve Therapeutics, Inc. (VERV) Stock Analysis: A Biotech Powerhouse with 34% Upside Potential

For investors with an eye on groundbreaking advancements in biotechnology, Verve Therapeutics, Inc. (NASDAQ: VERV) presents a compelling opportunity. As a clinical-stage company, Verve is at..

Abivax SA (ABVX) Stock Analysis: A 417% Upside Potential with Biotech Innovation

For investors on the lookout for high-potential opportunities in the biotech sector, Abivax SA (ABVX) presents a compelling case. With its focus on developing innovative therapeutics..

Bioventus Inc. (BVS): Stock Analysis and Investor Outlook with a Promising 85% Upside Potential

Bioventus Inc. (NASDAQ: BVS), headquartered in Durham, North Carolina, is making waves in the healthcare sector with its innovative medical devices aimed at alleviating pain and..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Healthcare Innovation Amidst Financial Challenges

For investors looking at the healthcare sector, Surmodics, Inc. (NASDAQ: SRDX) presents a compelling case of innovation coupled with financial turbulence. Based in Eden Prairie, Minnesota,..

Autolus Therapeutics (AUTL): Analyst Ratings Signal a 326% Upside Potential

Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based biopharmaceutical company, is capturing attention with its substantial upside potential in the biotechnology sector. With a market cap of..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Biotech Bet with a 318% Potential Upside

Relay Therapeutics, Inc. (NASDAQ: RLAY) stands as a compelling story in the biotechnology sector, with the promise of a significant upside that has captured the attention..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A Promising 80% Upside in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is rapidly gaining attention in the biotech sector, thanks to a compelling 80% potential upside and favorable analyst ratings. As a..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Unveiling Nearly 98% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS) stands out in the healthcare sector, particularly in the niche of drug manufacturers specializing in both specialty and generic products. With..

AngioDynamics, Inc. (ANGO): A 58.73% Upside Potential Amidst Healthcare Innovations

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, has been making waves with its innovative medical technologies aimed at treating peripheral vascular disease..

Celcuity Inc. (CELC) Investor Outlook: Unpacking a 137% Potential Upside in Biotech Innovation

In the dynamic landscape of biotechnology, Celcuity Inc. (NASDAQ: CELC) stands out as a promising player with significant growth potential. With its focus on developing targeted..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating an 87% Potential Upside in the Healthcare Sector

Standard BioTools Inc. (NASDAQ: LAB) presents a compelling opportunity for investors looking to explore the healthcare sector, particularly within the medical devices industry. With its current..

LifeMD, Inc. (LFMD) Stock Analysis: Telehealth Growth and Revenue Surge Propel Investor Interest

LifeMD, Inc. (NASDAQ: LFMD), a key player in the healthcare sector, is making waves in the health information services industry. Operating as a direct-to-patient telehealth company..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: A Promising 80% Upside in the Biotech Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP) stands out in the biotechnology sector with a market capitalization of $780.39 million and a focus on addressing unmet medical needs..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 353.99% Potential Upside in Biotech

Investors eyeing biotechnology companies with high-risk, high-reward potential may find Upstream Bio, Inc. (NASDAQ: UPB) intriguing. The company, headquartered in Waltham, Massachusetts, is at the forefront..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Unveiling a 121% Potential Upside

Cogent Biosciences, Inc. (NASDAQ: COGT), a burgeoning player in the biotechnology sector, is capturing attention due to its innovative approach to precision therapies for genetically defined..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Potential 9,737% Upside in Biotech

Cel-Sci Corporation (CVM), a clinical-stage biotechnology company, is capturing the attention of astute investors with its ambitious potential upside of 9,737.05%. Headquartered in Vienna, Virginia, Cel-Sci..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds